Mary Elizabeth (Betz) Halloran is an American biostatistician who works as a professor of biostatistics, professor of epidemiology, and adjunct professor of applied mathematics at the University of Washington. [1]
Halloran studied physics and philosophy of mathematics for two years as an undergraduate at Case Western Reserve University, from 1968 to 1970, [2] before leaving school to join the counterculture movement in San Francisco. [3] Deciding to study medicine, she returned to school, [3] completing a bachelor's degree in general science at the University of Oregon in 1972. [2]
She traveled to Berlin to continue her studies at the Max Planck Institute for Molecular Genetics and the Free University of Berlin from 1973 to 1975, [2] [3] studied medicine at the University of Southampton in England in 1981, and completed an M.D. at the Free University of Berlin in 1983. [2] Her goal at that time was to practice medicine in the developing world, [3] so she continued to study tropical diseases at the Bernhard Nocht Institute for Tropical Medicine in Hamburg in 1984, and then earned a master of public health degree from Harvard University in 1985. [2] In that program, she rekindled her interest in mathematical modeling, [3] and she stayed at Harvard as a graduate student, earning a D.Sc. in population sciences from Harvard in 1989. [2] [4]
After postdoctoral research at Princeton University and Imperial College London, she joined Emory University as an assistant professor of epidemiology and biostatistics in 1989, and was promoted to full professor in 1998. At Emory, she directed the Center for AIDS Research from 2002 to 2005, and the Center for Highthroughput Experimental Design and Analysis from 2004 to 2005. She moved to the University of Washington in 2005. In 2009, she founded the Summer Institute in Statistics and Modeling in Infectious Diseases at the University of Washington, and continues to serve as its director. [2]
Halloran studies causal inference and the biostatistics of infectious diseases. [3] She is a long-term collaborator with University of Florida researcher Ira Longini, with whom she studies the spread of influenza. [5] [6] She has also been quoted as an expert on the mortality rates of other diseases such as ebola and cholera, and the factors influencing those rates. [7]
With Longini and Claudio J. Struchiner, she is a co-author of the book Design and Analysis of Vaccine Studies (Springer, 2009). [8] [9] [10]
In 1996, Halloran was elected as a fellow of the American Statistical Association, in 1997 she became a fellow of the Royal Statistical Society, and in 2009 she became a fellow of the American Association for the Advancement of Science. [2] [11]
In 2005 and 2006 she held the Dr. Ross Prentice Professorship of Biostatistics at the University of Washington. [2]
An epidemic is the rapid spread of disease to a large number of hosts in a given population within a short period of time. For example, in meningococcal infections, an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered an epidemic.
Harvey Vernon Fineberg is an American physician. A noted researcher in the fields of health policy and medical decision making, his past research has focused on the process of policy development and implementation, assessment of medical technology, evaluation and use of vaccines, and dissemination of medical innovations. Fineberg has held several prominent positions over the course of his career, including Dean of the Harvard School of Public Health, Provost of Harvard University, and President of the Institute of Medicine, now the National Academy of Medicine.
Alessandro Vespignani is an Italian-American physicist, best known for his work on complex networks, and particularly for work on the applications of network theory to the mathematical modeling of infectious disease, applications of computational epidemiology, and for studies of the topological properties of the Internet. He is currently the Sternberg Family Distinguished University Professor of Physics, Computer Science and Health Sciences at Northeastern University, where he is the director of the Network Science Institute.
Maria Deloria Knoll is an expert in the fields of epidemiology, disease surveillance, vaccine trial conduct, and bio-statistics. She currently serves as associate director of Science at the International Vaccine Access Center (IVAC), an organization dedicated to accelerating global access to life-saving vaccines, at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.
The Center for Infectious Disease Research and Policy (CIDRAP) is a center within the University of Minnesota that focuses on addressing public health preparedness and emerging infectious disease response. It was founded in 2001 by Dr. Michael Osterholm, in order to "prevent illness and death from infectious diseases through epidemiological research and rapid translation of scientific information into real-world practical applications and solutions". It is not part of the Center for Disease Control or National Institute of Health.
The Oxford Vaccine Group (OVG) is a vaccine research group within the Department of Paediatrics at the University of Oxford. It was founded in 1994 by Professor E. Richard Moxon, was initially based at the John Radcliffe Hospital, and moved in 2003 to its current location in the Centre for Clinical Vaccinology and Tropical Medicine (CCVTM) at the Churchill Hospital in Oxford, England. The group, led by Professor Andrew Pollard since 2001, comprises around 75 members across a number of disciplines, including consultants in paediatrics and vaccinology, clinical research fellows, research nurses, statisticians, post-doctoral laboratory scientists, research assistants and DPhil students.
Ira M. Longini is an American biostatistician and infectious disease epidemiologist.
Christopher Mores is an American (US) arbovirologist, trained in infectious disease epidemiology. He is a professor in the Department of Global Health at the Milken Institute School of Public Health, the program director for the Global Health Epidemiology and Disease Control MPH program, and is director of a high-containment research laboratory at the George Washington University in Washington, DC.
John Brownstein is a Canadian epidemiologist and Professor of Medicine at the Harvard Medical School as well as the Chief Innovation Officer at Boston Children’s Hospital. His research focuses on development of computational methods in epidemiology for applications to public health also known as computational epidemiology or e-epidemiology He is also the founder of several global public health surveillance systems including HealthMap. He is most known for his work on global tracking of disease outbreaks.
Donald S. Burke is an expert on the prevention, diagnosis, and control of infectious diseases of global concern. He is a distinguished University Professor of Health Science and Policy at the University of Pittsburgh.
Donna Jean Brogan is an American statistician and professor emeritus of statistics at Emory University. Brogan has worked in biostatistical research in the areas of women's health, mental health and psychosocial health statistics, statistics on breast cancer, and analysis of complex survey data.
Roger I. Glass is an American physician-scientist who served as the Director of the John E. Fogarty International Center.
Daniel R. Lucey is an American physician, researcher, clinical professor of medicine of infectious diseases at Geisel School of Medicine at Dartmouth, and a research associate in anthropology at the Smithsonian National Museum of Natural History, where he has co-organised an exhibition on eight viral outbreaks.
Arnold Monto is an American physician and epidemiologist. At the University of Michigan School of Public Health, Monto is the Thomas Francis, Jr. Collegiate Professor Emeritus of Public Health, professor emeritus of both epidemiology and global public health, and co-director of the Michigan Center for Respiratory Virus Research & Response. His research focuses on the occurrence, prevention, and treatment of viral respiratory infections in industrialized and developing countries' populations.
Marc Lipsitch is an American epidemiologist and Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, where he is the Director of the Center for Communicable Disease Dynamics. He has worked on modeling the transmission of Coronavirus disease 2019 (COVID-19).
Natalie E. Dean is an American biostatistician specializing in infectious disease epidemiology. Dean is currently an assistant professor of Biostatistics at the University of Florida. Her research involves epidemiological modeling of outbreaks, including Ebola, Zika and COVID-19.
Helen Y. Chu is an American immunologist who is an assistant professor of medicine at the University of Washington. Her research considers maternal immunization, with a focus on influenza and respiratory syncytial virus. During the COVID-19 pandemic, Chu was the first physician to recognise community transmission of the coronavirus disease within the United States.
Megan Blanche Murray is an American epidemiologist and an infectious disease physician. She is the Ronda Stryker and William Johnston Professor of Global Health in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health.
Rebecca Allana Hubbard is an American biostatistician whose research interests include observational studies and the use of electronic health record data in public health analysis and decision-making, accounting for the errors in this type of data. She is a professor of biostatistics in the Perelman School of Medicine at the University of Pennsylvania.
Ann Marie Kimball is an American physician. She is known for being the pioneer of electronic disease surveillance for infectious disease outbreaks and pandemics. She is currently a Professor Emerita in the Department of Epidemiology at the University of Washington, a Consulting Fellow at the Chatham House Royal Institute of Foreign Affairs, and was a Strategic Consultant in Global Health at the Rockefeller Foundation. Kimball served as a technical and strategic lead for the Bill and Melinda Gates Foundation infectious disease surveillance strategy formation.